Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.

our clients
tiltle-brk

client-logo
client-logo2
client-logo3
client-logo4
client-logo
client-logo
client-logo
client-logo

"The quality of representation was outstanding. I never thought that understanding a complex market can be that much easy"

Adam Smith, Associate Director, Bain Capital

"More than just selling a report, the team was more focused towards the understanding of my requirements. Regular updation was the best part."

Koh Vivian, Product Development Manager, Swiss Bio Pharma

"Hats off to expert analysis, the team was very supporting and thanks for not charging me on additional data."

Erin Green, Director, Green Energy Consulting

" I really want to thank Goldstein Research for their efforts to make my project successful. F2F discussion with the market experts was excellent. Keep up the good work guyz "

Jorge Foyo, , Analyst, BCG
Market Research Report

Global Biologics Drug Discovery Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024

Published On : 2017-09-06 Report Page : 302 Category: Healthcare

Global Biologics Drug Discovery Market

Market Overview

The drug discovery process comprises of iterative cycles between chemistry and biology. Natural sources serve as compound of interest in drug discovery for the treatment of many diseases. Over 20 new drugs were launched in the market between 2000-2005, originated from terrestrial plants, terrestrial microorganisms, marine organisms and terrestrial vertebrates and invertebrates.

The drug discovery procedure is long, arduous and costly, which has encouraged outsourcing in the drug discovery field. The drug discovery market is driven by the factors such as rising geriatric population, increase in investments in this field due to the advancements in the field of biotechnology, microbiology, genetics and structural biology. However, slow pace of formulating the drug discovery projects by the government hinders the biologics drug discovery market.

For instance, the main purpose of Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection is to supply the Novartis drug discovery pipeline with hit to lead drugs/compounds for present and future portfolios of drug discovery programs. There are many drug discovery approaches targeting the cancerous cells by Novartis Institutes for Biomedical Research, Switzerland and Cambridge.      

Market Segmentation

By Technology

  • Q-PCR
  • DNA Microarrays
  • Protein Microarrays
  • High-throughput screening
  • Mass Spectrometry
  • Gel Electrophoresis
  • Chromatography
  • Protein and Nucleic Acid Isolation
  • Other technologies

By End User

  • Outsourcing (Contract Research Organization)
  • Insourcing (Within the Organization)

By Geography

  • North America (US, Canada) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Production (Units)}
  • Rest of the World{Market Share (%), Market Size (USD Billion), Production (Units)}

Growth Drivers and Challenges

The major driving factors of Biologics Drug Discovery Market are high prevalence of genetic disorders, nervous system disorders, diabetes and cardiovascular diseases along with advancement in the field of biotechnology, genetics, structural biology and molecular biology. Increase in health expenditure, highly robust, upsurge in the discovery of therapeutics ventures and populated drug pipeline for novel drugs. Furthermore, patents of drugs expire that tends to make the lucrative market for the existing players. In US and Canada biologics drug discovery market is high due to promising healthy potential returns on investments and high-income population.

However, shift from traditional methods to personalized drug discovery is hindering the global biologics drug discovery market. Delay in government approval for drug discovery and huge investment favoring the shift from market branded drugs to generic drugs are the challenges faced by biologics drug discovery market. Lower profit margins of pharmaceutical companies which are due to the huge investments made on drug discovery and consume time hampers the biologics drug discovery market.

Market Size and Forecast

The global market for biologics drug discovery market reached nearly USD 56.6 billion in 2016 and is expected to reach USD 140.9 billion by 2024 at the CAGR of 12% over the forecast period. High throughput screening is widely adopted drug discovery technology owing to the fact that it enables portfolio construction of biologically relevant compounds quickly. The global biologics drug discovery market North America holds the largest market share in the global drug discovery market owing to the concentration of world’s leading pharmaceutical companies. The US and Canadian Government have formulated encouraging policies for the investors to research and develop new drugs.

Key Market Players

  • Johnson and Johnson
    • Synopsis
    • Business Strategy
    • Product Portfolio
    • SWOT Analysis
  • Bayer AG
  • Sanofi
  • Novartis
  • AstraZeneca PLC
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Boehringer Ingelheim Inc.
  • Glaxosmithkline LLC
  • Eli Lily
  • Roche Holding AG.
  • Infosys
  • Charles River Laboratories
  • Albany Molecular Research Inc.
  • Boehringer Ingelheim GmBh
  • Covance
  • Jubilant Biosys

Scope Background

Market Synopsis

Market Segmentation

Global biologics drug discovery market is segmented as follows:

  • By  Technology (Market Size, Demand Analysis and Growth Analysis)
  • By  End User (Market Size, Demand Analysis and Growth Analysis)

Global Biologics Drug Discovery Market Report covered insights of below mentioned regions:

  • North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
  • Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
  • Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
  • Asia-Pacific (China, India, Singapore, Japan, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}
  • Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
  • Rest of World  {Market Size, Growth Analysis and Opportunity Analysis}

Market Dynamics: Growth Drivers, Restraints and Opportunities

  • Risk Factors
  • Regional Variations
  • Recent Trends and Developments

Key Market Players

  • Synopsis
  • Business Strategy
  • Product Portfolio
  • SWOT Analysis

Porter’s Five Force Model

Market Landscape: Competition and Beyond

Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem

Expert Analysis

Concluding Remarks


Biologics Drug Discovery Market- Table of Content

 

1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Data Analyzing & Market Size Estimation 
1.4. Research Design
1.5. Bottom-Up & Top-Down Approach
 
2. Market Environment
2.1. Global Economic Overview
2.2. Macroeconomic Outlook
2.3. Global Healthcare Industry Overview
2.4. Global Pharmaceuticals Industry Outlook
2.5. Global Genomic Research Outlook
2.6. Global Clinical Diagnostics Outlook
2.7. Global Drug Discovery Technology Outlook
2.8. Global Disease Prevalence Analysis
2.9. Regulatory & Environmental Considerations
 
3. Industry Structure
3.1. Target Consumer Group Analysis
3.2. Target Markets (By Countries)
3.3. Developed & Emerging Markets
3.4. Government & Private Investments Outlook
3.5. Healthcare Reforms Outlook
3.6. Cost Analysis
 
4. Executive Summary
4.1. Market Size (USD Million)
4.2. Forecast Analysis (2017-2025)
4.3. Market Share & CAGR (%)
4.4. Regional Share Distribution (%)
 
5. Market Dynamics
5.1. Growth Drivers
5.2. Market Restraints
5.3. Risk Analysis 
5.4. Recent Trends & Developments
5.5. Opportunities for Market Players
 
6. Global Biologics Drug DiscoveryMarket Segmentation
6.1. Biologics Drug Discovery Market on the Basis of Technology(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.1. Q-PCR (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.2. DNA Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.3. Protein Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.4. High-throughput screening (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.5. Mass Spectrometry(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.6. Gel Electrophoresis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.7. Chromatography (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.8. Protein and Nucleic Acid Isolation  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.9. Other Technologies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.1.10. Market Attractiveness by Technology Type in Biologics Drug Discovery Market
6.1.11. BPS Analysis by Technology Type in Biologics Drug Discovery Market
 
6.2. Biologics Drug Discovery Market on the Basis of Product (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.1. Monoclonal Antibody (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.2. Recombinant Protein (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.3. Other Biologics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.2.4. Market Attractiveness by Productin Biologics Drug Discovery Market
6.2.5. BPS Analysis by Productin Biologics Drug Discovery Market
 
6.3. Biologics Drug Discovery Market on the Basis of Discovery Phases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.1. Target Identification/Validation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.2. Hit Generation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.3. Lead Identification (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.4. Lead Optimization (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.3.5. Market Attractiveness by Discovery Phasesin Biologics Drug Discovery Market
6.3.6. BPS Analysis by Discovery Phasesin Biologics Drug Discovery Market
 
6.4. Biologics Drug Discovery Market on the Basis of End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.1. Outsourcing (Contract Research Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.2. Insourcing (Within the Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.4.3. Market Attractiveness by End-Userin Biologics Drug Discovery Market
6.4.4. BPS Analysis by End-Userin Biologics Drug Discovery Market
 
6.5. Global Biologics Drug Discovery Market By Region (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
 
6.5.1. North AmericaBiologics Drug Discovery Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.5.1.1. North AmericaBiologics Drug Discovery Market on the Basis of Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.1.1.1. U.S. Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.1.2. Canada (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.1.3. Market Attractiveness by Countryin Biologics Drug Discovery Market
6.5.1.1.4. BPS Analysis by Countryin Biologics Drug Discovery Market
 
6.5.1.2. North America Biologics Drug Discovery Market on the Basis of Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.1. Q-PCR (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.2. DNA Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.3. Protein Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.4. High-throughput screening (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.5. Mass Spectrometry(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.6. Gel Electrophoresis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.7. Chromatography (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.8. Protein and Nucleic Acid Isolation  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.9. Other Technologies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.2.10. Market Attractiveness by Technology Type in Biologics Drug Discovery Market
6.5.1.2.11. BPS Analysis by Technology Type in Biologics Drug Discovery Market
 
6.5.1.3. North America Biologics Drug Discovery Market on the Basis of Product (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.1. Monoclonal Antibody (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.2. Recombinant Protein (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.3. Other Biologics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.3.4. Market Attractiveness by Productin Biologics Drug Discovery Market
6.5.1.3.5. BPS Analysis by Productin Biologics Drug Discovery Market
 
6.5.1.4. North America Biologics Drug Discovery Market on the Basis of Discovery Phases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.1. Target Identification/Validation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.2. Hit Generation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.3. Lead Identification (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.4. Lead Optimization (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.4.5. Market Attractiveness by Discovery Phasesin Biologics Drug Discovery Market
6.5.1.4.6. BPS Analysis by Discovery Phasesin Biologics Drug Discovery Market
 
6.5.1.5. North America Biologics Drug Discovery Market on the Basis of End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.5.1. Outsourcing (Contract Research Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.5.2. Insourcing (Within the Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.1.5.3. Market Attractiveness by End-Userin Biologics Drug Discovery Market
6.5.1.5.4. BPS Analysis by End-Userin Biologics Drug Discovery Market
 
6.5.2. Europe Biologics Drug Discovery Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1. Europe Biologics Drug Discovery Market on the Basis of Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.2.1.1. UK Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.2. France (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.3. Italy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.4. Germany (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.5. Spain (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.6. Hungary (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.7. Sweden (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.8. Russia (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.9. Poland (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.10. Rest of Europe (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.1.11. Market Attractiveness by Countryin Biologics Drug Discovery Market
6.5.2.1.12. BPS Analysis by Countryin Biologics Drug Discovery Market
 
6.5.2.2. Europe Biologics Drug Discovery Market on the Basis of Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.1. Q-PCR (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.2. DNA Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.3. Protein Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.4. High-throughput screening (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.5. Mass Spectrometry(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.6. Gel Electrophoresis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.7. Chromatography (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.8. Protein and Nucleic Acid Isolation  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.9. Other Technologies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.2.10. Market Attractiveness by Technology Type in Biologics Drug Discovery Market 
6.5.2.2.11. BPS Analysis by Technology Type in Biologics Drug Discovery Market
 
6.5.2.3. Europe Biologics Drug Discovery Market on the Basis of Product (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.1. Monoclonal Antibody (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.2. Recombinant Protein (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.3. Other Biologics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.3.4. Market Attractiveness by Productin Biologics Drug Discovery Market
6.5.2.3.5. BPS Analysis by Productin Biologics Drug Discovery Market
 
6.5.2.4. Europe Biologics Drug Discovery Market on the Basis of Discovery Phases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.1. Target Identification/Validation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.2. Hit Generation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.3. Lead Identification (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.4. Lead Optimization (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.4.5. Market Attractiveness by Discovery Phasesin Biologics Drug Discovery Market
6.5.2.4.6. BPS Analysis by Discovery Phasesin Biologics Drug Discovery Market
 
6.5.2.5. Europe Biologics Drug Discovery Market on the Basis of End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.5.1. Outsourcing (Contract Research Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.5.2. Insourcing (Within the Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.2.5.3. Market Attractiveness by End-Userin Biologics Drug Discovery Market
6.5.2.5.4. BPS Analysis by End-Userin Biologics Drug Discovery Market
 
6.5.3. Middle East & Africa Biologics Drug Discovery Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.5.3.1. Middle East & Africa Biologics Drug Discovery Market on the Basis of Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.3.1.1. Gulf Cooperation Council Countries (GCC) Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1.2. South Africa (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1.3. North Africa (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1.4. Rest of Middle East and Africa (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.1.5. Market Attractiveness by Country in Biologics Drug Discovery Market
6.5.3.1.6. BPS Analysis by Countryin Biologics Drug Discovery Market
 
6.5.3.2. Middle East & Africa Biologics Drug Discovery Market on the Basis of Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.1. Q-PCR (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.2. DNA Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.3. Protein Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.4. High-throughput screening (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.5. Mass Spectrometry(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.6. Gel Electrophoresis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.7. Chromatography (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.8. Protein and Nucleic Acid Isolation  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.9. Other Technologies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.2.10. Market Attractiveness by Technology Type in Biologics Drug Discovery Market
6.5.3.2.11. BPS Analysis by Technology Type in Biologics Drug Discovery Market 
 
6.5.3.3. Middle East & Africa Biologics Drug Discovery Market on the Basis of Product (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.1. Monoclonal Antibody (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.2. Recombinant Protein (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.3. Other Biologics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.3.4. Market Attractiveness by Productin Biologics Drug Discovery Market
6.5.3.3.5. BPS Analysis by Productin Biologics Drug Discovery Market
 
6.5.3.4. Middle East & Africa Biologics Drug Discovery Market on the Basis of Discovery Phases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.1. Target Identification/Validation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.2. Hit Generation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.3. Lead Identification (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.4. Lead Optimization (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.4.5. Market Attractiveness by Discovery Phasesin Biologics Drug Discovery Market
6.5.3.4.6. BPS Analysis by Discovery Phasesin Biologics Drug Discovery Market
 
6.5.3.5. Middle East & Africa Biologics Drug Discovery Market on the Basis of End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.5.1. Outsourcing (Contract Research Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.5.2. Insourcing (Within the Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.3.5.3. Market Attractiveness by End-Userin Biologics Drug Discovery Market
6.5.3.5.4. BPS Analysis by End-Userin Biologics Drug Discovery Market
 
6.5.4. Latin America Biologics Drug Discovery Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.5.4.1. Latin America Biologics Drug Discovery Market on the Basis of Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.4.1.1. Brazil Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.1.2. Mexico (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.1.3. Rest of Latin America (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.1.4. Market Attractiveness by Country in Biologics Drug Discovery Market
6.5.4.1.5. BPS Analysis by Countryin Biologics Drug Discovery Market
 
6.5.4.2. Latin America Biologics Drug Discovery Market on the Basis of Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.1. Q-PCR (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.2. DNA Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.3. Protein Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.4. High-throughput screening (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.5. Mass Spectrometry(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.6. Gel Electrophoresis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.7. Chromatography (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.8. Protein and Nucleic Acid Isolation  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.9. Other Technologies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.2.10. Market Attractiveness by Technology Type in Biologics Drug Discovery Market
6.5.4.2.11. BPS Analysis by Technology Type in Biologics Drug Discovery Market
 
6.5.4.3. Latin America Biologics Drug Discovery Market on the Basis of Product (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.1. Monoclonal Antibody (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.2. Recombinant Protein (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.3. Other Biologics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.3.4. Market Attractiveness by Productin Biologics Drug Discovery Market
6.5.4.3.5. BPS Analysis by Productin Biologics Drug Discovery Market
 
6.5.4.4. Latin America Biologics Drug Discovery Market on the Basis of Discovery Phases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.1. Target Identification/Validation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.2. Hit Generation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.3. Lead Identification (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.4. Lead Optimization (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.4.5. Market Attractiveness by Discovery Phasesin Biologics Drug Discovery Market
6.5.4.4.6. BPS Analysis by Discovery Phasesin Biologics Drug Discovery Market
 
6.5.4.5. Latin America Biologics Drug Discovery Market on the Basis of End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.5.1. Outsourcing (Contract Research Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.5.2. Insourcing (Within the Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.4.5.3. Market Attractiveness by End-Userin Biologics Drug Discovery Market
6.5.4.5.4. BPS Analysis by End-Userin Biologics Drug Discovery Market
 
6.5.5. Asia Pacific (APAC) Biologics Drug Discovery Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
 
6.5.5.1. Asia Pacific Biologics Drug Discovery Market on the Basis of Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
6.5.5.1.1. China Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.2. Japan (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.3. India (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.4. Singapore (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.5. South Korea (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.6. Australia (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.7. New Zealand (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.8. Rest of APAC (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.1.9. Market Attractiveness by Country in Biologics Drug Discovery Market
6.5.5.1.10. BPS Analysis by Countryin Biologics Drug Discovery Market
 
6.5.5.2. Asia Pacific Biologics Drug Discovery Market on the Basis of Technology (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.1. Q-PCR (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.2. DNA Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.3. Protein Microarrays (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.4. High-throughput screening (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.5. Mass Spectrometry(Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.6. Gel Electrophoresis (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.7. Chromatography (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.8. Protein and Nucleic Acid Isolation  (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.9. Other Technologies (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.2.10. Market Attractiveness by Technology Type in Biologics Drug Discovery Market
6.5.5.2.11. BPS Analysis by Technology Type in Biologics Drug Discovery Market
 
6.5.5.3. Asia Pacific Biologics Drug Discovery Market on the Basis of Product (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.1. Monoclonal Antibody (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.2. Recombinant Protein (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.3. Other Biologics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.3.4. Market Attractiveness by Productin Biologics Drug Discovery Market
6.5.5.3.5. BPS Analysis by Productin Biologics Drug Discovery Market
 
6.5.5.4. Asia Pacific Biologics Drug Discovery Market on the Basis of Discovery Phases (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.1. Target Identification/Validation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.2. Hit Generation (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.3. Lead Identification (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.4. Lead Optimization (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.4.5. Market Attractiveness by Discovery Phasesin Biologics Drug Discovery Market
6.5.5.4.6. BPS Analysis by Discovery Phasesin Biologics Drug Discovery Market
 
6.5.5.5. Asia Pacific Biologics Drug Discovery Market on the Basis of End-User (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.5.1. Outsourcing (Contract Research Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.5.2. Insourcing (Within the Organization) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
6.5.5.5.3. Market Attractiveness by End-Userin Biologics Drug Discovery Market
6.5.5.5.4. BPS Analysis by End-Userin Biologics Drug Discovery Market
 
7. Competitive Outlook
7.1. Market Share of Major Players (2016)
7.2. Company Profiles
7.2.1. Johnson and Johnson
7.2.1.1. Company Synopsis
7.2.1.2. Business Strategy
7.2.1.3. Product Portfolio
7.2.1.4. SWOT Analysis
7.2.2. Bayer AG
7.2.3. Sanofi
7.2.4. Novartis
7.2.5. AstraZeneca PLC
7.2.6. Pfizer Inc.
7.2.7. Merck & Co. Inc.
7.2.8. BoehringerIngelheim Inc.
7.2.9. Glaxosmithkline LLC
7.2.10. Eli Lily
7.2.11. Roche Holding AG. 
7.2.12. Infosys
7.2.13. Charles River Laboratories
7.2.14. Albany Molecular Research Inc.
7.2.15. BoehringerIngelheimGmBh
7.2.16. Covance
7.2.17. Jubilant Biosys
 
8. Porter’s Five Force Model
9. Market Landscape: Competition and Beyond
10. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
11. Expert Analysis
12. Concluding Remarks

Global Biologics Drug Discovery Market Outlook 2024: Global Opportunity and Demand Analysis, Market Forecast, 2016-2024

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747